News

The valve-making procedure, which could spare children born with heart defects the need to undergo repeated surgeries, is licensed to UMN startup Vascudyne.

On March 3, faculty, staff, students, and members of the broader national research community gathered virtually to discuss how the pandemic is changing research ethics.

The state is looking to expand Minnesota’s role as a national leader in innovation—and University of Minnesota experts are lending their support.

The new apple, a cross of Honeycrisp and Liberty, is red with a tart flavor and should be available in grocery stores in three to four years.

Tech Comm has been working hard to elevate issues related to diversity, equity, and inclusion (DEI).  As part of this commitment, Tech Comm recently hired a part-time DEI contractor, Michelle Maryns.

Claros Technologies' antiviral textiles provide enhanced protection from COVID-19 when compared with other masks on the market.

Minnesotans' investment in the University made it possible for researchers to quickly develop technologies to address COVID-19 health needs. 

In his Annual Report on the Status of Research and Technology Commercialization before the Board of Regents today, Vice President for Research Christopher J. Cramer credited University of Minnesota’s research community for record productivity and a remarkable pivot to COVID-19 safety protocols and COVID-19-related work. 

Friday, December 18, OVPR and UMN Technology Commercialization will host an online conversation with USPTO Director and Under Secretary of Commerce for Intellectual Property, Andrei Iancu.

Catamaran Bio, a biotechnology startup developing new cancer treatments, has raised $42 million in venture capital.